Latest News
COSCIENS Biopharma Inc.
- COSCIENS Biopharma Inc. Estimates – TSX:CSCI
- COSCIENS Biopharma Inc.: What Investors Should Watch Next (TSXV:CSCI)
- Is COSCIENS Biopharma (TSX:CSCI) Positioning Nualtis For Its Next Chapter?
- COSCIENS raises $12M in convertible debentures to fund Nualtis deal
- COSCIENS Biopharma Inc. (TSX:CSCI) on the S&P/TSX Radar: Biopharma Pipeline and Cash Runway Remain Central to Investor Debate
- COSCIENS Biopharma Inc.
- COSCIENS、新たな企業プレゼンテーションを発表し、転換社債発行に関する最新情報を提供
- COSCIENS Biopharma Inc. (TSX:CSCI) Rises 2.92% as Buying Momentum Supports a Constructive Outlook
- COSCIENS updates on convertible debenture offering and posts new corporate presentation after Nualtis acquisition
- COSCIENS Biopharma Inc. (TSX:CSCI) Stock Falls 7.29%: Clinical Pipeline Execution Pacing, Post-Merger Commercial Integration, and Life Sciences Valuation Compression Examined
- Why Is COSCIENS Biopharma Stock Down 5.41%? Key Drivers and What Investors Are Watching (TSX:CSCI)
- COSCIENS Biopharma Stock Falls 5.41% as Acquisition Financing Shapes a Cautious Outlook
Headlines from the last 30 days, linking to the original publishers. See all market news →